Stocks losers - Yahoo Finance

UK Markets closed
Loading...
  • RR.L
    Financial Times17 hours ago

    [$$] UK investigation into Rolls-Royce turns its focus to individuals

    In 2009, Rolls-Royce paid £3.32m to rent a Dubai warehouse for eight months to store defence products destined for the Indian market. The only problem was that, apart from a test run, no Rolls-Royce stock ...

  • Shire's (SHPG) ADHD Candidate's NDA Accepted by FDA
    SHP.L
    Zacks23 hours ago

    Shire's (SHPG) ADHD Candidate's NDA Accepted by FDA

    Shire plc (SHPG) announced that the FDA has acknowledged receipt of the Class 2 resubmission of a New Drug Application (NDA) for pipeline candidate, SHP465.

  • AZN.L
    Reutersyesterday

    Bristol-Myers lung cancer delay slams shares, keeps Merck in lead

    Bristol-Myers Squibb Co (BMY.N) shares fell 11 percent on Friday following Thursday's announcement that it would not seek accelerated approval of its immunotherapy drug combination in first-line lung cancer, further solidifying Merck & Co Inc's (MRK.N) leading position in the burgeoning immuno-oncolgy field. Lung cancer is by far the biggest oncology market and a handful of companies have been battling to become dominant in initial, or first-line, treatment, and to provide much-needed combination therapies. Merck shares rose 3.6 percent to $62.53, while Bristol fell to $49.23.